KALA BIO, INC. Debt Instrument, Face Amount
KALA BIO, INC. (KALA) had Debt Instrument, Face Amount of $43.30 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentFaceAmount · last filed 2022-11-08
- 2022-09-30: Debt Instrument, Face Amount $43.30M.
- 2022-06-30: Debt Instrument, Face Amount $80.00M.
- 2022-03-31: Debt Instrument, Face Amount $80.00M.
- 2021-12-31: Debt Instrument, Face Amount $80.00M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2022-09-30 | $43.30M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $80.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $80.00M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $80.00M 10-Q · filed 2022-11-08 |
| 2021-09-30 | $80.00M 10-Q · filed 2021-11-15 |
| 2020-12-31 | $75.00M 10-Q · filed 2021-11-15 |
| 2018-12-31 | $75.00M 10-K · filed 2020-02-12 |
| 2017-12-31 | $84.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |